{"id":4673,"date":"2025-03-31T18:12:16","date_gmt":"2025-03-31T18:12:16","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/salbutamol-txt\/"},"modified":"2025-03-31T18:12:16","modified_gmt":"2025-03-31T18:12:16","slug":"salbutamol-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/salbutamol-txt\/","title":{"rendered":"salbutamol.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3><br \/>\nBeta2-adrenoceptor agonist:Reversible airways disease <H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>Oral: 2\u20134 mg 3\u20134 times daily SC\/IM: 500 micrograms, repeated 4 hourly  if necessaryIV: 250 micrograms slow bolus, repeated  if requiredInfusion: start with 5 micrograms\/minute,  adjust according to response, usually 3\u201320 micrograms\/minuteAerosol: 100\u2013200 micrograms (1\u20132 puffs)  4 times dailyPowder: 200\u2013400 micrograms 4 times  dailyNebulisation: 2.5\u20135 mg 4 times daily, or  more frequently<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :239.3<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :10<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 51\u201364<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :2\u20132.5<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :4\u20136\/Unchanged<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4><LI> 20 to 50  &amp;nbsp &amp;nbsp : Dose as in normal renal function <LI> 10 to 20  &amp;nbsp &amp;nbsp : Dose as in normal renal function <LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Dose as in normal renal function<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Unknown dialysability. Dose as in normal renal function <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Unknown dialysability. Dose as in normal renal function <LI>HDF\/high flux  &amp;nbsp :Unknown dialysability. Dose as in normal renal function <LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Unknown dialysability. Dose as in normal renal function<H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugsIncreased risk of hypokalaemia when  diuretics, theophylline or large doses of corticosteroids are given with high doses of salbutamolAntihypertensives: acute hypotension with  <H4> IV infusion  <\/H4> of salbutamol and methyldopa<H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>\u2013<H4>  Route  <\/H4>IV, SC, IM, oral, inhaled, nebulised <H4>  Rate of Administration  <\/H4>IV slow bolus; <H4> IV infusion  <\/H4> 3\u201320  micrograms\/minute<H4>Comments<\/H4>Infusion: dilute 10 mL (10 mg) to 500 mL  with sodium chloride 0.9% or glucose 5% (20 micrograms\/mL)Via syringe pump: dilute 10 mL (10 mg)  to 50 mL with sodium chloride 0.9% or glucose 5% (200 micrograms\/mL)<H4>  OTHER INFORMATION  <\/H4>Monitor ECG\/BP\/pulse Nebulised salbutamol may be prescribed  for hypokalaemic effect in acute hyperkalaemia (unlicensed).<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Beta2-adrenoceptor agonist:Reversible airways disease DOSE IN NORMAL RENAL<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4673","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4673"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4673\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}